Purple willow.

Salix purpurea and Salix alba both supply salicin, which becomes salicylic acid by the same two-step conversion. Combining them stacks salicylate exposure without adding a distinct action. Since bark salicin content varies several fold by species and harvest, the combined dose is harder to estimate than either alone.

Salicin is inactive as swallowed. Colonic bacteria cleave the sugar to release saligenin, which the liver then oxidises to salicylic acid. That makes microbial capacity a real determinant of how much salicylate a given bark dose produces, and it explains why onset is slow compared with a direct salicylate. Whether adding a supplemental probiotic strain measurably changes this conversion has not been demonstrated.

The main elimination route for salicylate is conjugation with glycine in the liver, and that pathway saturates at higher salicylate loads. Adequate glycine supply is a precondition for the pathway rather than a way to speed it up in someone already replete. This is biochemistry, not a demonstrated interaction with willow bark specifically.

Salicylate lowers thromboxane production through cyclooxygenase, and EPA shifts eicosanoid output toward less aggregatory species. The two reach the same endpoint by different steps, so bruising and bleeding time can extend more than either would alone. This matters most around surgery or with anticoagulant medicine.

Ginger constituents reduce platelet aggregation in laboratory and small human work, though the effect at culinary intakes is modest. Stacked on a salicylate source the direction is the same. The signal is mechanistic and marker-level rather than a demonstrated bleeding outcome.

Garlic reduces platelet aggregation in human studies, measured as a marker rather than as a clinical bleeding event. Added to a salicylate-yielding bark, the effects run in the same direction. Worth flagging before any planned procedure.

Nattokinase acts on fibrin while salicylate acts on platelets, so the two hit different steps of the same overall process. Combining them extends the clotting picture further than either does alone. There is no trial of the pair, so this is reasoning from each one's known action.

Curcumin lowers platelet aggregation in cell and animal work, with limited human confirmation at ordinary supplement doses given its poor absorption. The direction of any effect matches salicylate's. Read this as a caution flag rather than an established clinical interaction.

At supplemental doses well above dietary intake, alpha-tocopherol has been shown to extend bleeding time, an effect that is negligible at food-level intake. On top of a salicylate source the two add. The concern applies to high-dose supplementation, not to a multivitamin.

Bark preparations contain condensed tannins alongside salicin, and those tannins complex non-heme iron before it can be absorbed. Taking bark extract with an iron capsule reduces the delivered dose. Two hours of separation removes most of the overlap.

Ascorbate holds iron in the ferrous state and competes with polyphenols for it, recovering part of what tannins would otherwise bind. The offset is partial. Separating the bark from the iron dose is the more reliable move.

Bromelain has fibrinolytic and antiplatelet activity in laboratory work, with thin human data. Combined with a salicylate source the direction is additive. Flag it before procedures rather than assume a measurable clinical effect.